Drug Index

Agalsidase Alfa/Beta


Indication :

  • Enzyme replacement for Fabry’s Disease

Dosing :

Agalsidase alfa: 0.2 mg/kg as IV infusion over 40 mins. Repeat 2 weekly.
Agalsidase beta: 1 mg/kg as IV infusion over 4-6 hours. Repeat 2 weekly.

Adverse Effect :

Injection site pain, headache, flushing, fever, rigors, abdominal pain, chest pain, diarrhea, dizziness, eczema, hypertension, myalgia, URI, nausea, vomiting.


Hepatic Dose :

No dosage adjustments are recommended.
02/20/2021 12:21:38 Agalsidase Alfa/Beta
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0